ARCHIVES

NCI prepares for third hearing on conflicts of interest.

This article is from The Cancer Letter archive.

Vol. 30 No. 25 | June 18, 2004

Download PDF Visit The Full Archive

Related Articles

Nine Cancer Act Changes Considered By NCAB Subcommittee

September 3, 1976

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

Healy’s “Save Bob” Campaign

January 6, 1995

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

Needed Enhancement Or Unfunded Mandate? New NCI Program To Merge CCOP, NCCCP

July 13, 2012

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014